Plain-language · Issue 1 · 2026-09-24
Lower Neighborhood Opportunity Linked to Higher Hospitalization Risk in Children with Cystic Fibrosis
Editorially reviewed research summaries, context, and limitations.
Ashley Han, Matt Hall, Elizabeth Cromwell, et al.
Summary: Researchers linked two large databases — one tracking CF patients across the US and one tracking hospital visits at children's hospitals — to study more than 8,000 children with CF over thirteen years. They used a tool called the Childhood Opportunity Index, which measures how much access a neighborhood provides to good schools, healthcare, clean environments, and economic stability. Children living in neighborhoods with the lowest scores were 60% more likely to be hospitalized for breathing problems than children in the highest-scoring neighborhoods. The pattern held across other types of hospital and emergency room visits as well.
Why it matters: For families and clinicians, this study puts numbers to something many in the CF community already sense: where a child grows up and lives has a measurable effect on how often they end up in hospital. As new CF treatments have become available and dramatically improved outcomes for many children, understanding why some children still face high rates of hospitalization is an urgent and practical question. If neighborhood conditions independently shape a child's risk of serious illness, that has direct implications for how care teams and health systems should plan support.
What to keep in mind: The neighborhood opportunity score is a broad area-level measure — it reflects the average conditions in a zip code or census tract, not what any individual family actually experiences. Two children living in the same neighborhood can have very different home circumstances. The study also cannot rule out the possibility that children in lower-opportunity neighborhoods tend to have more severe CF disease or less access to newer treatments, and those differences — not the neighborhood itself — may partly explain the higher hospitalization rates. The study covers 2009 to 2022, a period that saw the introduction of transformative new CF medicines toward the end. Whether these neighborhood differences in hospitalization have grown smaller, stayed the same, or grown larger since those medicines became widely available is an important question this study cannot answer.
Relevance: CF Registry and Real-World Evidence
Source: https://pubmed.ncbi.nlm.nih.gov/42697797/
---